{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T06:24:27Z","timestamp":1789280667049,"version":"build-2803163510"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.psychres.2025.116443","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T19:23:41Z","timestamp":1742066621000},"page":"116443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Measuring suicidal behavior in the era of rapid-acting antidepressants: A systematic review of ketamine studies"],"prefix":"10.1016","volume":"348","author":[{"given":"Fl\u00e1via","family":"Vieira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Teresa","family":"Caliman-Fontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Breno","family":"Souza-Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8076-514X","authenticated-orcid":false,"given":"Daniela","family":"Faria-Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Lins-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassio","family":"Santos-Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0389-1940","authenticated-orcid":false,"given":"Ana Paula","family":"Jesus-Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8807-8464","authenticated-orcid":false,"given":"Lucas C.","family":"Quarantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2025.116443_bib0001","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-067194","article-title":"Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial","volume":"376","author":"Abbar","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.psychres.2025.116443_bib0002","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jad.2023.01.005","article-title":"Antidepressant and anti-suicidal effects of ketamine in treatment-resistant depression associated with psychiatric and personality comorbidities: a double-blind randomized trial","volume":"325","author":"Ahmed","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2025.116443_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.113495","article-title":"Suicide ideation and behavior assessment tool (SIBAT): evaluation of intra- and inter-rater reliability, validity, and mapping to Columbia classification algorithm of suicide assessment","volume":"294","author":"Alphs","year":"2020","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2025.116443_bib0004","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2022.01.104","article-title":"mTORC1 inhibitor effects on rapid ketamine-induced reductions in suicidal ideation in patients with treatment-resistant depression","volume":"303","author":"Averill","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2025.116443_bib0005","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1176\/appi.ajp.161.12.2163","article-title":"The Hamilton depression rating scale: has the Gold Standard become a lead weight?","volume":"161","author":"Bagby","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.598434","article-title":"New methods for assessing rapid changes in suicide risk","volume":"12","author":"Ballard","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0007","doi-asserted-by":"crossref","first-page":"pyu069","DOI":"10.1093\/ijnp\/pyu069","article-title":"Neural correlates of suicidal ideation and its reduction in depression","volume":"18","author":"Ballard","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2025.116443_bib0009","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1037\/pas0000053","article-title":"A systematic review and evaluation of measures for suicidal ideation and behaviors in population-based research","volume":"27","author":"Batterham","year":"2015","journal-title":"Psychol. Assess."},{"key":"10.1016\/j.psychres.2025.116443_bib0010","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1037\/0022-006X.47.2.343","article-title":"Assessment of suicidal intention: the scale for suicide ideation","volume":"47","author":"Beck","year":"1979","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.psychres.2025.116443_bib0011","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/1097-4679(198807)44:4<499::AID-JCLP2270440404>3.0.CO;2-6","article-title":"Scale for suicide ideation: psychometric properties of a self-report version","volume":"44","author":"Beck","year":"1988","journal-title":"J. Clin. Psychol."},{"key":"10.1016\/j.psychres.2025.116443_bib0012","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0013","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0014","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s40596-014-0180-1","article-title":"A review of multidisciplinary clinical practice guidelines in Suicide prevention: toward an emerging standard in suicide risk assessment and management, training and practice","volume":"38","author":"Bernert","year":"2014","journal-title":"Acad. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0015","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3109\/00207454.2014.933834","article-title":"Combination therapy utilizing ketamine and transcranial magnetic stimulation for treatment-resistant depression: a case report","volume":"125","author":"Best","year":"2015","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.psychres.2025.116443_bib0016","doi-asserted-by":"crossref","first-page":"h4978","DOI":"10.1136\/bmj.h4978","article-title":"Suicide risk assessment and intervention in people with mental illness","volume":"351","author":"Bolton","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.psychres.2025.116443_bib0018","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.7205\/MILMED-D-15-00431","article-title":"A double-blinded, randomized, placebo-controlled sub-dissociative dose ketamine pilot study in the treatment of acute depression and suicidality in a military emergency department setting","volume":"181","author":"Burger","year":"2016","journal-title":"Mil. Med."},{"key":"10.1016\/j.psychres.2025.116443_bib0019","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1037\/neu0000850","article-title":"Concurrent validity and reliability of suicide risk assessment instruments: a meta-analysis of 20 instruments across 27 international cohorts","volume":"37","author":"Campos","year":"2023","journal-title":"Neuropsychology"},{"key":"10.1016\/j.psychres.2025.116443_bib0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41398-021-01230-z","article-title":"Low dose oral ketamine treatment in chronic suicidality: an open-label pilot study","volume":"11","author":"Can","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0021","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1176\/appi.ajp.2018.17060720","article-title":"Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: results of a double-blind, randomized, placebo-controlled study","volume":"175","author":"Canuso","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0022","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jad.2022.07.054","article-title":"The effect of IV ketamine in patients with major depressive disorder and elevated features of borderline personality disorder","volume":"315","author":"Chen","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2025.116443_bib0023","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jad.2019.03.075","article-title":"Antisuicidal effect, BDNF Val66Met polymorphism, and low-dose ketamine infusion: reanalysis of adjunctive ketamine study of Taiwanese patients with treatment-resistant depression (AKSTP-TRD)","volume":"251","author":"Chen","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2025.116443_bib0025","series-title":"Suicide Probability Scale Manual","author":"Cull","year":"1988"},{"key":"10.1016\/j.psychres.2025.116443_bib0026","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1600-0447.1986.tb02723.x","article-title":"The montgomery-\u00c5sberg depression scale: reliability and validity","volume":"73","author":"Davidson","year":"1986","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2025.116443_bib0027","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4088\/JCP.07m03904","article-title":"The duration of the suicidal process: how much time is left for intervention between consideration and accomplishment of a suicide attempt?","volume":"70","author":"Deisenhammer","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0028","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eurpsy.2014.06.005","article-title":"Bipolar I and II versus unipolar depression: clinical differences and impulsivity\/aggression traits","volume":"30","author":"Dervic","year":"2015","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0029","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jad.2011.11.013","article-title":"Is it valid to measure suicidal ideation by depression rating scales?","volume":"136","author":"Desseilles","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2025.116443_bib0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jpsychires.2021.09.002","article-title":"Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: results from the Canadian rapid treatment centre of excellence","volume":"143","author":"Di Vincenzo","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2025.116443_bib0031","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jpsychires.2021.02.058","article-title":"The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: a systematic review","volume":"137","author":"Di Vincenzo","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2025.116443_bib0032","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0269881114527361","article-title":"Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic","volume":"28","author":"Diamond","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116443_bib0033","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.4088\/JCP.09m05327blu","article-title":"Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder","volume":"71","author":"DiazGranados","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0034","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jaac.2017.01.006","article-title":"Ketamine as a treatment for adolescent depression: a case report","volume":"56","author":"Dwyer","year":"2017","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0035","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1089\/cap.2022.0013","article-title":"Letter to the editor: antidepressant and antisuicidal effects of esketamine in adolescents with major depressive disorder and suicidal ideation: a case series","volume":"32","author":"Faria-Guimar\u00e3es","year":"2022","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116443_bib0036","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.euroneuro.2021.04.024","article-title":"The effect of single administration of intravenous ketamine augmentation on suicidal ideation in treatment-resistant unipolar depression: results from a randomized double-blind study","volume":"49","author":"Feeney","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2025.116443_bib0037","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00115-021-01260-4","article-title":"Practical aspects of ketamine treatment-safety, combination treatment and comorbidities","volume":"93","author":"Findeis","year":"2022","journal-title":"Nervenarzt"},{"key":"10.1016\/j.psychres.2025.116443_bib0038","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s40263-022-00916-2","article-title":"Evaluation of individual items of the Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) in adults with treatment-resistant depression treated with esketamine nasal spray combined with a new oral antidepressant","volume":"36","author":"Floden","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2025.116443_bib0039","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s40596-015-0349-2","article-title":"Suicide risk assessment and management in practice: the quintessential clinical activity","volume":"39","author":"Fochtmann","year":"2015","journal-title":"Acad. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0040","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m13191","article-title":"Esketamine nasal spray for rapid reduction of major depressive disorder symptoms in patients who have active suicidal ideation with intent: double-blind, randomized study (ASPIRE I)","volume":"81","author":"Fu","year":"2020","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0041","first-page":"66","article-title":"The Columbia\u2013suicide severity rating scale (C\u2013SSRS): has the \u201cGold standard\u201d become a liability?","volume":"11","author":"Giddens","year":"2014","journal-title":"Innov. Clin. Neurosci."},{"key":"10.1016\/j.psychres.2025.116443_bib0042","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1176\/appi.ajp.2017.17060647","article-title":"Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial","volume":"175","author":"Grunebaum","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0043","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0044","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jad.2020.12.120","article-title":"Ketamine's rapid antisuicidal effects are not attenuated by Buprenorphine","volume":"282","author":"Hosanagar","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2025.116443_bib0045","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1017\/S0033291715002159","article-title":"Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study","volume":"46","author":"Hu","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2025.116443_bib0046","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.psychres.2025.116443_bib0047","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jad.2018.09.037","article-title":"Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: a randomized, double blind, placebo controlled trial","volume":"243","author":"Ionescu","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2025.116443_bib0048","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/ijnp\/pyaa068","article-title":"Esketamine nasal spray for rapid reduction of depressive symptoms in patients with major depressive disorder who have active suicide ideation with intent: results of a phase 3, double-blind, randomized study (ASPIRE II)","volume":"24","author":"Ionescu","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2025.116443_bib0049","doi-asserted-by":"crossref","first-page":"e719","DOI":"10.4088\/JCP.15m10056","article-title":"Rapid and sustained reductions in current suicidal ideation following repeated doses of intravenous ketamine: secondary analysis of an open-label study","volume":"77","author":"Ionescu","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0050","unstructured":"Janssen, 2020. Janssen announces U.S. FDA approval of SPRAVATO\u00ae (esketamine) CIII nasal spray to treat depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior."},{"key":"10.1016\/j.psychres.2025.116443_bib0051","unstructured":"Janssen Pharmaceuticals, Inc., 2020. SPRAVATO\u00ae [Prescribing Information]."},{"key":"10.1016\/j.psychres.2025.116443_bib0052","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.4088\/JCP.15m10253","article-title":"Evidence to support Montgomery-Asberg Depression Rating Scale administration every 24 hours to assess rapid onset of treatment response","volume":"77","author":"Johnson","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0053","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1755-5949.2010.00151.x","article-title":"Why has the antidepressant-placebo difference in antidepressant clinical trials diminished over the past three decades?: declining antidepressant placebo differences in clinical trials","volume":"16","author":"Khan","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.psychres.2025.116443_bib0054","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/JCP.0000000000001289","article-title":"Comparison of rapid antidepressant and antisuicidal effects of intramuscular ketamine, oral ketamine, and electroconvulsive therapy in patients with major depressive disorder: a pilot study","volume":"40","author":"Kheirabadi","year":"2020","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116443_bib0055","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.psychres.2025.116443_bib0056","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0920-9964(02)00335-3","article-title":"The InterSePT scale for suicidal thinking reliability and validity","volume":"63","author":"Lindenmayer","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2025.116443_bib0057","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jad.2022.09.043","article-title":"Real-world experience of esketamine use to manage treatment-resistant depression: a multicentric study on safety and effectiveness (REAL-ESK study)","volume":"319","author":"Martinotti","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2025.116443_bib0058","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/sltb.12791","article-title":"Examining suicide assessment measures for research use: using item response theory to optimize psychometric assessment for research on suicidal ideation in major depressive disorder","volume":"51","author":"McCall","year":"2021","journal-title":"Suicide Life Threat. Behav."},{"key":"10.1016\/j.psychres.2025.116443_bib0059","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst. Rev."},{"key":"10.1016\/j.psychres.2025.116443_bib0060","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0061","doi-asserted-by":"crossref","unstructured":"Moola, S., Munn, Z., Tufanaru, C., Aromataris, E., Sears, K., Sfetcu, R., Currie, M., Qureshi, R., Mattis, P., Lisy, K., Mu, P.F., 2020. Chapter 7: systematic reviews of etiology and risk., in: JBI Manual for Evidence Synthesis. JBI.","DOI":"10.46658\/JBIRM-17-06"},{"key":"10.1016\/j.psychres.2025.116443_bib0062","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.psiq.2016.11.002","article-title":"Ketamine in the treatment of suicidal ideation associated with resistant depression. A case report","volume":"24","author":"Mora","year":"2017","journal-title":"Psiquiatr. Biol."},{"key":"10.1016\/j.psychres.2025.116443_bib0063","doi-asserted-by":"crossref","unstructured":"Morey, L.C., 1991. The personality assessment inventory professional manual. Odessa FL Psychol. Assess. Resour.","DOI":"10.1037\/t03903-000"},{"key":"10.1016\/j.psychres.2025.116443_bib0064","series-title":"The Corsini Encyclopedia of Psychology","first-page":"1","article-title":"Personality Assessment Inventory","author":"Morey","year":"2010"},{"key":"10.1016\/j.psychres.2025.116443_bib0065","doi-asserted-by":"crossref","unstructured":"Munn, Z., Barker, T.H., Moola, S., Tufanaru, C., Stern, C., McArthur, A., Stephenson, M., Aromataris, E., 2019. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Database Syst. Rev. Implement. Rep. Publish Ahead of Print. 10.11124\/JBISRIR-D-19-00099.","DOI":"10.11124\/JBISRIR-D-19-00099"},{"key":"10.1016\/j.psychres.2025.116443_bib0066","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00737-007-0192-x","article-title":"Suicidal ideation in pregnancy: assessment and clinical implications","volume":"10","author":"Newport","year":"2007","journal-title":"Arch. Womens Ment. Health"},{"key":"10.1016\/j.psychres.2025.116443_bib0067","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jamapsychiatry.2022.1074","article-title":"Evaluation of the trajectory of depression severity with ketamine and esketamine treatment in a clinical setting","volume":"79","author":"Nikayin","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0068","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/0956797610364762","article-title":"Measuring the suicidal mind: implicit cognition predicts suicidal behavior","volume":"21","author":"Nock","year":"2010","journal-title":"Psychol. Sci."},{"key":"10.1016\/j.psychres.2025.116443_bib0069","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/pcn.13379","article-title":"Different symptomatic improvement pattern revealed by factor analysis between placebo response and response to Esketamine in treatment resistant depression","volume":"76","author":"Ohnishi","year":"2022","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2025.116443_bib0070","first-page":"540","article-title":"Use of intranasal esketamine in a girl with treatment-resistant depression and autism spectrum disorders: a case report","volume":"21","author":"Olivola","year":"2022","journal-title":"EXCLI J."},{"key":"10.1016\/j.psychres.2025.116443_bib0071","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/wps.20396","article-title":"Suicide risk assessment: tools and challenges","volume":"16","author":"Oquendo","year":"2017","journal-title":"World Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0072","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2466\/pr0.1998.82.3.783","article-title":"The positive and negative suicide ideation inventory: development and validation","volume":"82","author":"Osman","year":"1998","journal-title":"Psychol. Rep."},{"key":"10.1016\/j.psychres.2025.116443_bib0073","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/bdi.12464","article-title":"Incidence and predictors of suicide attempts in bipolar I and II disorders: a 5-year follow-up study","volume":"19","author":"Pallaskorpi","year":"2017","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.psychres.2025.116443_bib0074","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41386-019-0570-x","article-title":"Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression","volume":"45","author":"Phillips","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2025.116443_bib0075","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia\u2013suicide severity rating scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0076","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1176\/ajp.2007.164.7.1035","article-title":"Columbia classification algorithm of suicide assessment (C-CASA): classification of suicidal events in the FDA's Pediatric Suicidal risk Analysis of antidepressants","volume":"164","author":"Posner","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0077","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/da.22253","article-title":"Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression","volume":"31","author":"Price","year":"2014","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.psychres.2025.116443_bib0078","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.biopsych.2009.04.029","article-title":"Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression","volume":"66","author":"Price","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0079","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2004.02.001","article-title":"Suicide attempts: differences between unipolar and bipolar patients and among groups with different lethality risk","author":"Raja","year":"2004","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2025.116443_bib0080","series-title":"Suicidal Ideation Questionnaire","author":"Reynolds","year":"1987"},{"key":"10.1016\/j.psychres.2025.116443_bib0081","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.865466","article-title":"Efficacy and safety of intranasal esketamine in patients with treatment-resistant depression and comorbid chronic post-traumatic stress disorder: open-label single-arm pilot study","volume":"13","author":"Roth\u00e4rmel","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0082","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180292","article-title":"Instruments for the assessment of suicide risk: a systematic review evaluating the certainty of the evidence","volume":"12","author":"Runeson","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.psychres.2025.116443_bib0083","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1176\/appi.ajp.2013.13081034","article-title":"Ketamine for treatment-resistant depression: ready or not for clinical use?","volume":"170","author":"Rush","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0084","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","article-title":"The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression","volume":"54","author":"Rush","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0085","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1176\/appi.ajp.2019.18101219","article-title":"Treatment-resistant depression and ketamine response in a patient with bilateral amygdala damage","volume":"176","author":"Scheele","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0086","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jad.2018.07.073","article-title":"Ketamine augmentation for major depressive disorder and suicidal ideation: preliminary experience in an inpatient psychiatry setting","volume":"241","author":"Sinyor","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2025.116443_bib0087","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.282.18.1737","article-title":"Validation and utility of a self-report version of PRIME-MDThe PHQ primary care Study","volume":"282","author":"Spitzer","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.psychres.2025.116443_bib0088","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.psychres.2025.116443_bib0089","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/ijnp\/pyad014","article-title":"A randomized, double-blind, midazolam-controlled trial of low-dose ketamine infusion in patients with treatment-resistant depression and prominent suicidal ideation","volume":"26","author":"Su","year":"2023","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2025.116443_bib0090","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.psym.2013.12.002","article-title":"Beneficial pre-ECT ketamine infusion in a patient with treatment-resistant depression","volume":"55","author":"Sultan","year":"2014","journal-title":"Psychosomatics"},{"key":"10.1016\/j.psychres.2025.116443_bib0091","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s40261-022-01193-z","article-title":"Efficacy and safety of subcutaneous esketamine in the treatment of suicidality in major depressive disorder and bipolar depression","volume":"42","author":"Surjan","year":"2022","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.psychres.2025.116443_bib0092","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0140-6736(15)00234-2","article-title":"Suicide and suicidal behaviour","volume":"387","author":"Turecki","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2025.116443_bib0093","unstructured":"U.S. Food and Drug Administration, 2012. Guidance for industry: suicidal ideation and behavior: prospective assessment of occurrence in clinical trials."},{"key":"10.1016\/j.psychres.2025.116443_bib0094","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/sltb.12084","article-title":"The suicidal ideation attributes scale (SIDAS): community-based validation study of a new scale for the measurement of suicidal ideation","volume":"44","author":"van Spijker","year":"2014","journal-title":"Suicide Life Threat. Behav."},{"key":"10.1016\/j.psychres.2025.116443_bib0095","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/JCP.0000000000000960","article-title":"Efficacy and safety of a rapid intravenous injection of ketamine 0.5 mg\/kg in treatment-resistant major depression: an open 4-week longitudinal study","volume":"38","author":"Vidal","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116443_bib0096","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.genhosppsych.2020.12.011","article-title":"Ketamine and esketamine augmentation for suicidal ideation: a randomized, double-blinded clinical trial","volume":"68","author":"Vieira","year":"2021","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0097","article-title":"Suicide versus accidental death by autoerotic asphyxiation in a patient receiving intravenous ketamine for depression","volume":"2022","author":"Weleff","year":"2022","journal-title":"Case Rep. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0098","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1186\/s12889-024-19726-w","article-title":"Challenges in the evaluation of suicide prevention measures and quality of suicide data in Germany, Austria, and Switzerland: findings from qualitative expert interviews","volume":"24","author":"Werdin","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.psychres.2025.116443_bib0099","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0100","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.1020214","article-title":"Case report: medical student types journals during ketamine infusions for suicidal ideation, treatment-resistant depression, post-traumatic stress disorder, and generalized anxiety disorder","volume":"13","author":"Willms","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116443_bib0101","series-title":"Preventing Suicide: a Global Imperative","year":"2014"},{"key":"10.1016\/j.psychres.2025.116443_bib0102","unstructured":"World Health Organization, 2021. Suicide worldwide in 2019: global health estimates."},{"key":"10.1016\/j.psychres.2025.116443_bib0103","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jpsychires.2020.12.038","article-title":"The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: a systematic review and meta-analysis","volume":"134","author":"Xiong","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2025.116443_bib0104","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1177\/0269881119827811","article-title":"Investigation of medical effect of multiple ketamine infusions on patients with major depressive disorder","volume":"33","author":"Zheng","year":"2019","journal-title":"J. Psychopharmacol."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125000927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125000927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:48:25Z","timestamp":1777956505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178125000927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":101,"alternative-id":["S0165178125000927"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116443","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measuring suicidal behavior in the era of rapid-acting antidepressants: A systematic review of ketamine studies","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116443"}}